HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

MHP 133

structure given in first source

Also Known As:

1-(methyl-3-(N,N-dimethylcarbamoyloxy)-2-pyridylmethylene)-4-(4-phenyl)diazinecarboxamide chloride; MHP-133

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Pyridinium Compounds: 5
      - MHP 133: 1

Experts

1.	Buccafusco, Jerry J: 1 article (07/2007)
2.	Hernandez, Maria A: 1 article (07/2007)
3.	Jonnala, Ramamohana R: 1 article (07/2007)
4.	Powers, James C: 1 article (07/2007)
5.	Prendergast, Mark A: 1 article (07/2007)
6.	Terry, Alvin V: 1 article (07/2007)

Related Diseases

1.	Neurodegenerative Diseases (Neurodegenerative Disease) 07/01/2007 - "The results of this study are consistent with the potential use of MHP-133 in the treatment of neurodegenerative disorders such as Alzheimer's disease." 07/01/2007 - "MHP-133 is one of a novel series of compounds designed to target multiple brain substrates expected to have synergistic actions in the treatment of cognitive and neurodegenerative disorders such as Alzheimer's disease. "
2.	Alzheimer Disease (Alzheimer's Disease) 07/01/2007 - "The results of this study are consistent with the potential use of MHP-133 in the treatment of neurodegenerative disorders such as Alzheimer's disease." 07/01/2007 - "MHP-133 is one of a novel series of compounds designed to target multiple brain substrates expected to have synergistic actions in the treatment of cognitive and neurodegenerative disorders such as Alzheimer's disease. "